Quick Takeaways
- James Basta has 1 issuer position tracked on this page.
- Estimated disclosed ownership value: $2,160,621.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of James Basta
- Location
- San Diego, CA
- Summary
- The estimated net worth of James Basta is at least $2,160,621 dollars as of 03 Mar 2026. James Basta is the EVP, General Counsel of Intellia Therapeutics, Inc. and owns shares of Intellia Therapeutics, Inc. (NTLA) stock worth about $2.16M.
- Signature
- James Basta
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow James Basta and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
What Changed
- Largest disclosed position: Intellia Therapeutics, Inc. ($2,160,621).
- Past-year value change for that position: -$112,444.
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of James Basta
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| NTLA | Intellia Therapeutics, Inc. | EVP, General Counsel | $2,160,621 | -$112,444 | -4.9% | 01 Mar 2026 |
Insider Transactions Reported by James Basta:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.